Physician profile
Nicholas Mechas
NPI 1164886362
$7,985.81
in general payments reported to CMS, 2019-2025
9 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what 90% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,759 · 2020: $660 · 2021: $1,247 · 2022: $762 · 2023: $725 · 2024: $1,278 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,556.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,482.48 | 2019-2021 | |
| Stryker Corporation | $2,047.60 | 2020-2025 | Na, Vsp System, Vsp Cranial, Smartlock |
| Kls-Martin L.P. | $1,658.64 | 2021-2025 | |
| Axogen | $816.67 | 2021-2025 | |
| Straumann USA LLC | $388.31 | 2022-2025 | |
| Depuy Synthes Sales INC. | $380.24 | 2021-2025 | Trumatch, Matrixmandible |
| Zimmer Biomet Holdings, INC. | $173.06 | 2023 | |
| Zimvie INC. | $24.09 | 2025 | |
| Terumo Bct, INC. | $14.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Mechas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.